This study was to explore CHEK2 gene mutation in humanbreast cancer, and assess the value of assay of Tumor Specific Growth Factor (TSGF), CA15-3, CA125 and CEA in the diagnosis of breast cancer.
Objective: To evaluate the killing effect of tumor-selective replicating adenovirus CNHK300 combined with paclitaxel (chemotherapy agents) on humanbreast cancer cells over-expressing HER-2.